References
- GLOBOCAN . Estimated cancer incidence, mortality and prevalence worldwide in 2012 [Internet]. Lyon : International Agency for Research on Cancer (IARC); 2012, c2016 [2014 Jan 9], Available from: http://globocan.iarc.fr.
- Sung JJ , Lau JY , Goh KL , et al. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6:871–876.
- Bishehsari F , Mahdavinia M , Vacca M , et al. Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol. 2014;20:6055–6072.
- Norat T, Chan D, Lau R, et al. WCRF/AICR Systematic literature review - continuous update project report. The associations between food, nutrition and physical activity and the risk of Colorectal Cancer. World Cancer Research Fund/American Institute for Cancer Research; 2010. Available from: http://www.wcrf.org/sites/default/files/SLR_colorectal_cancer_2010.pdf.
- Migliore L , Migheli F , Spisni R , et al. Genetics, cytogenetics and epigenetics of colorectal cancer. J Biomed Biotechnol [Internet]. 2011 [cited 2016 Jan 4];2011:792362. Available from: http://www.hindawi.com/journals/bmri/2011/792362/.
- Peters U , Jiao S , Schumacher FR , et al. Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology. 2013;144:799–807.
- Markowitz SD , Bertagnolli MM . Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449–2460.
- Bartel DP , MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.
- Cui C , Yu J , Huang S , et al. Transcriptional regulation of gene expression by microRNAs as endogenous decoys of transcription factors. Cell Physiol Biochem. 2014;33:1698–1714.
- Ambros V . The functions of animal microRNAs. Nature. 2004;431:350–355.
- Meister G , Tuschl T . Mechanisms of gene silencing by double-stranded RNA. Nature. 2004;431:343–349.
- Zeng Y , Wagner EJ , Cullen BR . Both natural and designed microRNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell. 2002;9:1327–1333.
- Long D , Lee R , Williams P , et al. Potent effect of target structure on microRNA function. Nat Struct Mol Biol. 2007;14:287–294.
- Lim LP , Lau NC , Weinstein EG , et al. The microRNAs of Caenorhabditis elegans . Genes Dev. 2003;17:991–1008.
- Lim LP , Glasner ME , Yekta S , et al. Vertebrate microRNA genes. Science. 2003;299:1540.
- He L , Thomson JM , Hemann MT , et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435:828–833.
- Iorio MV , Croce CM . MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27:5848–5856.
- Ryan BM , Robles AI , Harris CC . Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10:389–402.
- Landi D , Gemignani F , Naccarati A , et al. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis. 2008;29:579–584.
- Yu Z , Li Z , Jolicoeur N , et al. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res. 2007;35:4535–4541.
- Arora A , Singh S , Bhatt AN , et al. Interplay between metabolism and oncogenic process: role of microRNAs. Transl Oncogenomics. 2015;7:11–27.
- Yin Y , Song M , Gu B , et al. Systematic analysis of key miRNAs and related signaling pathways in colorectal tumorigenesis. Gene. 2016;578:177–184.
- Zhang QJ , Xu C . The role of microRNAs in the pathogenesis of pituitary tumors. Front Biosci (Landmark Ed). 2016;21:1–7.
- Navarro A , Muñoz C , Gaya A , et al. MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients. PLoS One [Internet]. 2013 [cited 2013 May 21];8:e64716. Available from: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0064716.
- Horikawa Y , Wood CG , Yang H , et al. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res. 2008;14:7956–7962.
- Hu Z , Chen J , Tian T , et al. Genetic variants of miRNA equences and non-small cell lung cancer survival. J Clin Invest. 2008;118:2600–2608.
- Peng C , Guo Z , Wu X , et al. A polymorphism at the microRNA binding site in the 3' untranslated region of RYR3 is associated with outcome in hepatocellular carcinoma. Onco Targets Ther. 2015;8:2075–2079.
- Yang B , Liu C , Diao L , et al. A polymorphism at the microRNA binding site in the 3′ untranslated region of C14orf101 is associated with non-Hodgkin lymphoma overall survival. Cancer Genet. 2014;207:141–146.
- Xie Y , Diao L , Zhang L , et al. A miR-SNP of the KRT81 gene is associated with the prognosis of non-Hodgkin's lymphoma. Gene. 2014;539:198–202.
- de Larrea CF , Navarro A , Tejero R , et al. Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation. Clin Cancer Res. 2012;18:3697–3704.
- Zhao Y , Du Y , Zhao S , et al. Single-nucleotide polymorphisms of microRNA processing machinery genes and risk of colorectal cancer. Onco Targets Ther. 2015;8:421–425.
- Imai K , Kawai M , Tada M , et al. Temporal change in mKIAA gene expression during the early stage of retinoic acid-induced neurite outgrowth. Gene. 2005;364:114–122.
- Nakajima D , Okazaki N , Yamakawa H , et al. Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones. DNA Res. 2002;9:99–106.
- Nakayama M , Iida M , Koseki H , et al. A gene-targeting approach for functional characterization of KIAA genes encoding extremely large proteins. FASEB J. 2006;20:1718–1720.
- Schaffrik M , Mack B , Matthias C , et al. Molecular characterization of the tumor-associated antigen AAA-TOB3. Cell Mol Life Sci. 2006;63:2162–2174.